This inventor holds 1 USPTO granted patent. Top assignees: Bayer Aktiengesellschaft, Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12,269 
1 out of 1,269 
1 out of 490 
Years Active: 2026
Title: The Innovations of Jérémie Xavier Mortier
Introduction
Jérémie Xavier Mortier is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on substituted heterocyclic compounds. His research and inventions have the potential to impact therapeutic applications significantly.
Latest Patents
Mortier holds a patent for "Substituted heterocyclic compounds and therapeutic uses thereof." This patent includes compounds of formula (I), detailing the process for their production and their use as pharmaceuticals. His work in this area showcases his commitment to advancing medical science.
Career Highlights
Throughout his career, Mortier has worked with prominent companies, including Bayer Aktiengesellschaft and The Broad Institute, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Anne Mengel. Their partnership has likely fostered innovative ideas and advancements in their respective fields.
Conclusion
Jérémie Xavier Mortier's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for future innovations in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile